NASDAQ: CELZ
Creative Medical Technology Holdings Inc Stock Ownership - Who owns Creative Medical Technology Holdings?

Insider buying vs selling

Have Creative Medical Technology Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael H. FingerDirector2025-02-19750$5.75
$4.31kSell
Michael H. FingerDirector2025-02-18750$5.00
$3.75kSell

1 of 1

CELZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CELZ insiders and whales buy or sell their stock.

CELZ Shareholders

What type of owners hold Creative Medical Technology Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC5.72%148,000$583.12kInstitution
Timothy Warbington1.35%34,904$137.52kInsider
Geode Capital Management LLC0.71%18,268$71.98kInstitution
Vanguard Group Inc0.68%17,629$69.46kInstitution
Hrt Financial LP0.50%13,053$51.43kInstitution
Tower Research Capital LLC Trc0.12%3,152$12.42kInstitution
Osaic Holdings Inc0.05%1,261$4.97kInstitution
Michael H. Finger0.01%351$1.38kInsider
Bank Of America Corp0.00%122$480.68Institution
Org Partners LLC0.00%80$315.20Institution

1 of 2

CELZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CELZ7.80%1.36%Net Selling
CAPS0.00%51.09%
CDIO25.06%74.94%Net Buying
RNAZ38.03%61.97%
PMCB8.28%16.40%

Creative Medical Technology Holdings Stock Ownership FAQ

Who owns Creative Medical Technology Holdings?

Creative Medical Technology Holdings (NASDAQ: CELZ) is owned by 7.80% institutional shareholders, 1.36% Creative Medical Technology Holdings insiders, and 90.84% retail investors. Timothy Warbington is the largest individual Creative Medical Technology Holdings shareholder, owning 34,904.00 shares representing 1.35% of the company. Timothy Warbington's Creative Medical Technology Holdings shares are currently valued at $100.17k.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.